A novel long non-coding RNA in the rheumatoid arthritis risk locus TRAF1-C5 influences C5 mRNA levels

Genes and Immunity

Volumn 17, Issue 2, 2016, Pages 85-92

  Messemaker, T C ^a   Frank Bertoncelj, M ^b   Marques, R B ^a   Adriaans, A ^a   Bakker, A M ^a   Daha, N ^a   Gay, S ^b   Huizinga, T W ^a   Toes, R E M ^a   Mikkers, H M M ^a   Kurreeman, F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5; LONG UNTRANSLATED RNA; MESSENGER RNA; SPACER DNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; ALPHA AMANITIN; NUCLEIC ACID SYNTHESIS INHIBITOR; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; ARTICLE; CELLS BY BODY ANATOMY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE LOCUS; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LIVER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; TRANSCRIPTION REGULATION; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GENETICS; GENOTYPE; METABOLISM; MONOCYTE; PATHOLOGY; PRIMARY CELL CULTURE; SINGLE NUCLEOTIDE POLYMORPHISM; SYNOVIUM; TUMOR CELL LINE;

ALPHA-AMANITIN; ARTHRITIS, RHEUMATOID; CELL LINE, TUMOR; DNA, INTERGENIC; FIBROBLASTS; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATOCYTES; HUMANS; MONOCYTES; NUCLEIC ACID SYNTHESIS INHIBITORS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRIMARY CELL CULTURE; RNA, LONG NONCODING; RNA, MESSENGER; RNA, SMALL INTERFERING; SYNOVIAL MEMBRANE; TRANSCRIPTION, GENETIC;

EID: 84959559197     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2015.54     Document Type: Article

References (61)

1. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12: 861-874.
2. Churchill GA, Holland MJ, Draghici S, Khatri P, Eklund AC, Szallasi Z., et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007; 316: 1484-1488.
3. Hangauer MJ, Vaughn IW, McManus MT. Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs. PLoS Genet 2013; 9: e1003569.
4. Van Leeuwen S, Mikkers H. Long non-coding RNAs: guardians of development. Differentiation 2010; 80: 175-183.
5. Geisler S, Coller J. RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol 2013; 14: 699-712.
6. Xia T, Liao Q, Jiang X, Shao Y, Xiao B, Xi Y., et al. Long noncoding RNA associatedcompeting endogenous RNAs in gastric cancer. Sci Rep 2014; 4: 6088.
7. Wang X, Arai S, Song X, Reichart D, Du K, Pascual G., et al. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 2008; 454: 126-130.
8. Yap KL, Li S, Muñoz-Cabello AM, Raguz S, Zeng L, Mujtaba S., et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 2010; 38: 662-674.
9. Terranova R, Yokobayashi S, Stadler MB, Otte AP, van Lohuizen M, Orkin SH., et al. Polycomb group proteins Ezh2 and Rnf2 direct genomic contraction and imprinted repression in early mouse embryos. Dev Cell 2008; 15: 668-679.
10. Tsai M, Manor O, Wan Y, Mosammaparast N, Wang JK, Shi Y., et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 2010; 329: 689-693.
11. Pandey RR, Mondal T, Mohammad F, Enroth S, Redrup L, Komorowski J., et al. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell 2008; 32: 232-246.
12. Nagano T, Mitchell JA, Sanz LA, Pauler FM. The air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 2008; 322: 1717-1720.
13. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H., et al. The GENCODE v7 catalog of human long noncoding RNAs : analysis of their gene structure, evolution, and expression. Genome Res 2012; 22: 1775-1789.
14. Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H., et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 2014; 42: D1001-D1006.
15. Holdt LM, Hoffmann S, Sass K, Langenberger D, Scholz M, Krohn K., et al. Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks. PLoS Genet 2013; 9: e1003588.
16. Kurreeman F a S, Padyukov L, Marques RB, Schrodi SJ, Seddighzadeh M, Stoeken- Rijsbergen G., et al. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med 2007; 4: e278.
17. Plenge RM, Seielstad M, Padyukov L, Lee T, Remmers EF, Ding B., et al. TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. NEJM 2007; 357: 1199-1209.
18. Lavorgna A, De Filippi R, Formisano S, Leonardi A. TNF receptor-associated factor 1 is a positive regulator of the NF-kappaB alternative pathway. Mol Immunol 2009; 46: 3278-3282.
19. Ma X, Xu S. TNF inhibitor therapy for rheumatoid arthritis. Biomed Rep 2013; 1: 177-184.
20. Cooke TD, Hurd ER, Jasin HE, Bienenstock J, Ziff M. Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. Arthritis Rheum 1975; 18: 541-551.
21. Wang Y, Kristan J, Hao L, Lenkoski CS, Shen Y, Matis LA. A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. J Immunol 2000; 164: 4340-4347.
22. Dunkelberger JR, Song W-C. Complement and its role in innate and adaptive immune responses. Cell Res 2010; 20: 34-50.
23. Su X, Li S, Meng M, Qian W, Xie W, Chen D., et al. TNF receptor-associated factor-1 (TRAF1) negatively regulates Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling. Eur J Immunol 2006; 36: 199-206.
24. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009; 106: 9362-9367.
25. Messemaker T, Toes REM, Kurreeman F, Mikkers HMM. Comment on "functional analysis of a complement polymorphism (rs17611) associated with rheumatoid arthritis. J Immunol 2015; 195: 3-4.
26. Ding J, Eyre S, Worthington J. Genetics of RA susceptibility, what comes next?. RMD Open 2015; 1: e000028-e000028.
27. Messemaker TC, Huizinga TW, Kurreeman F. Immunogenetics of rheumatoid arthritis: understanding functional implications. J Autoimmun 2015; 64: 74-81.
28. Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K., et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2013; 506: 376-381.
29. Volders P-J, Helsens K, Wang X, Menten B, Martens L, Gevaert K., et al. LNCipedia: a database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res 2013; 41: D246-D251.
30. Chakraborty S, Deb A, Maji RK, Saha S, Ghosh Z. LncRBase: an enriched resource for lncRNA information. PLoS One 2014; 9: e108010.
31. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-vega B, Regev A., et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 2011; 25: 1915-1927.
32. Mercer TR, Gerhardt DJ, Dinger ME, Crawford J, Trapnell C, Jeddeloh JA., et al. Targeted RNA sequencing reveals the deep complexity of the human transcriptome. Nat Biotechnol 2012; 30: 99-104.
33. Warfel AH. Specific Inhibition of nuclear RNA polymerase II by a-Amanitin. Science 1970; 170: 447-449.
34. Kim T-K, Hemberg M, Gray JM, Costa AM, Bear DM, Wu J., et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 2010; 465: 182-187.
35. Ren B. Transcription: enhancers make non-coding RNA. Nature 2010; 465: 173-174.
36. Tuck AC, Tollervey D. A transcriptome-wide atlas of RNP composition reveals diverse classes of mRNAs and lncRNAs. Cell 2013; 154: 996-1009.
37. Liu X, Gorovsky M.A. Mapping the 5' and 3' ends of Tetrahymena therrmophila mRNAs using RNA ligase mediated amplification of cDNA ends (RLM-RACE). Nucleic Acids Res 1993; 21: 4954-4960.
38. Lizio M, Harshbarger J, Shimoji H, Severin J, Kasukawa T, Sahin S., et al. Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol 2015; 16: 22.
39. Desmet F-O, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 2009; 37: e67.
40. Kozak M, Limited IRLP. An analysis of 5-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 1987; 15: 8125-8148.
41. Nishikawa T, Ota T, Isogai T. Prediction whether a human cDNA sequence contains initiation codon by combining statistical information and similarity with protein sequences. Bioinformatics 2000; 16: 960-967.
42. Kong L, Zhang Y, Ye Z-Q, Liu X-Q, Zhao S-Q, Wei L., et al. CPC: assess the proteincoding potential of transcripts using sequence features and support vector machine. Nucleic Acids Res 2007; 35: W345-W349.
43. Imamura K, Imamachi N, Akizuki G, Kumakura M, Kawaguchi A, Nagata K., et al. Long noncoding RNA NEAT1-dependent SFPQ relocation from promoter region to paraspeckle mediates IL8 expression upon immune stimuli. Mol Cell 2014; 53: 393-406.
44. Marn-Béjar O, Marchese FP, Athie A, Snchez Y, Gonzlez J, Segura V., et al. Pint lincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2. Genome Biol 2013; 14: R104.
45. Lee JT, Bartolomei MS. X-inactivation, imprinting, and long noncoding RNAs in health and disease. Cell 2013; 152: 1308-1323.
46. Han L, Zhang E, Yin D, Kong R, Xu T, Chen W., et al. Low expression of long noncoding RNA PANDAR predicts a poor prognosis of non-small cell lung cancer and affects cell apoptosis by regulating Bcl-2. Cell Death Dis 2015; 6: e1665.
47. IIott NE, Heward JA, Roux B, Tsitsiou E, Fenwick PS, Lenzi L., et al. Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes. Nat Commun 2014; 5: 3979.
48. Chen G, Wang Z, Wang D, Qiu C, Liu M, Chen X., et al. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res 2013; 41: D983-D986.
49. Kumar V, Westra H-J, Karjalainen J, Zhernakova D V, Esko T, Hrdlickova B., et al. Human disease-associated genetic variation impacts large intergenic non-coding RNA expression. PLoS Genet 2013; 9: e1003201.
50. Kallen AN, Zhou X-B, Xu J, Qiao C, Ma J, Yan L., et al. The imprinted H19 LncRNA antagonizes Let-7 microRNAs. Mol Cell 2013; 52: 101-112.
51. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
52. Engreitz JM, Sirokman K, McDonel P, Shishkin AA, Surka C, Russell P., et al. RNA-RNA interactions enable specific targeting of noncoding RNAs to nascent Pre-mRNAs and chromatin sites. Cell 2014; 159: 188-199.
53. Kapusta A, Kronenberg Z, Lynch VJ, Zhuo X, Ramsay L, Bourque G., et al. Transposable elements are major contributors to the origin, diversification, and regulation of vertebrate long noncoding RNAs. PLoS Genet 2013; 9: e1003470.
54. Gong C, Maquat LE. lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3 UTRs via Alu elements. Nature 2011; 470: 284-288.
55. Kretz M, Siprashvili Z, Chu C, Webster DE, Zehnder A, Qu K., et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature 2013; 493: 231-235.
56. Faghihi MA, Modarresi F, Khalil AM, Wood DE, Sahagan BG, Morgan TE., et al. Expression of a noncoding RNA is elevated in Alzheimers disease and drives rapid feed-forward regulation of B-secretase expression. Nat Med 2008; 14: 723-730.
57. Naslavsky MS, Crovella S, Lima Filho JL, Rocha CRC. The sound of silence: human beta-defensin-1 gene untranslated SNPs change the predicted mRNA secondary structure in a length-dependent manner. Immunol Lett 2010; 129: 53-55.
58. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
59. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
60. Rosenbloom KR, Armstrong J, Barber GP, Casper J, Clawson H, Diekhans M., et al. The UCSC Genome Browser database: 2015 update. Nucleic Acids Res 2015; 43 (Database issue): D670-D681.
61. Bai Y, Soda Y, Izawa K, Tanabe T, Kang X, Tojo A., et al. Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector. Gene Ther 2003; 10: 1446-1457.